Nasdaq Technology

Friday, September 18, 2020The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (JPM), PayPal (PYPL) and Novo Nordisk (NVO). These research reports have be

Since the pandemic lows in late March, the Dow has surged by more than 59%, the S&P by 63%, and the Nasdaq by 81%!It’s been a record-setting move.And in spite of the pandemic, both the S&P and Nasdaq (even with the recent pullback), are positive on the year with the S&

Investors should consider allocating to longer-term tech and healthcare exposures specifically focusing on forward-looking megatrend areas of innovation versus traditional sector approaches.

The Nasdaq Q-50 Index (NXTQ) is a “minor league” of sorts for stocks that are viable candidates for future admission into the Nasdaq-100. Thanks to the recent launch of the VictoryShares Nasdaq Next 50 ETF (QQQN), investors have an avenue for accessing the Q-50.

The Michaels Companies MIK topped our second quarter estimates at the start of September and it posted its strongest sales growth in years as people looked to keep busy while staying home. And the arts and craft-focused retailer’s outlook appears even stronger heading into the

A month has gone by since the last earnings report for TJX (TJX). Shares have added about 8.3% in that time frame, outperforming the S&P 500.

It has been about a month since the last earnings report for Synopsys (SNPS). Shares have lost about 6.2% in that time frame, underperforming the S&P 500.

A month has gone by since the last earnings report for Target (TGT). Shares have lost about 3% in that time frame, underperforming the S&P 500.

A month has gone by since the last earnings report for Nordson (NDSN). Shares have added about 2% in that time frame, outperforming the S&P 500.

A month has gone by since the last earnings report for Nvidia (NVDA). Shares have added about 2.7% in that time frame, outperforming the S&P 500.

A month has gone by since the last earnings report for Lowe's (LOW). Shares have added about 3.3% in that time frame, outperforming the S&P 500.

A month has gone by since the last earnings report for L Brands (LB). Shares have added about 2.5% in that time frame, outperforming the S&P 500.

It has been about a month since the last earnings report for Cosan (CZZ). Shares have lost about 3.4% in that time frame, underperforming the S&P 500.

A month has gone by since the last earnings report for Analog Devices (ADI). Shares have lost about 1.7% in that time frame, underperforming the S&P 500.

There is no better feeling for an investor than trusting your gut or doing your research and timing the markets correctly, right?

There is no better feeling for an investor than trusting your gut or doing your research and timing the markets correctly, right?

The funds in our "Magnificent Retirement Mutual Funds" list are among the best managed and best performing mutual funds available. If you are just finding out about our Top-Ranked Funds list, we welcome you!

If you're invested in any of the funds in our "Magnificent Retirement Mutual Funds" list, congratulations on owning some of the best managed and top-performing mutual funds. If you are lucky enough to discover our list of Top-Ranked Funds for the first time, it's never too late

The funds in our "Magnificent Retirement Mutual Funds" list are among the best managed and best performing mutual funds available. If you are just finding out about our Top-Ranked Funds list, we welcome you!

ChemoCentryx, Inc., CCXI announced that the FDA has acceptedits new drug application (NDA) seeking approval for its investigational candidate, avacopan, for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis (ANCA-associated vasculitis), a rare autoimmun